Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Diversa identifies new therapeutic leads on the ocean floor

Feb. 18, 1998

CellPro: Q3 1998 highlights

Feb. 18, 1998

SIDDCO expands combinatorial chemistry consortium

Feb. 17, 1998

Lead compounds identified in Warner-Lambert/Trega collaboration

Feb. 17, 1998

NanoSystems to develop new formulation of Boehringer Ingelheim drug

Feb. 17, 1998

Trega and Ono expand R&D collaboration

Feb. 16, 1998

Schering-Plough and Transgene gene delivery collaboration

Feb. 16, 1998

Medarex and Schering AG sign antibody agreement

Feb. 12, 1998

New implant for delivery of LHRH agonists

Feb. 11, 1998

Roche and deCODE Genetics form genomics collaboration

Feb. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...